DrugPatentWatch Database Preview

Drugs in Development Information for Ibudilast

« Back to Dashboard

Summary for Ibudilast

US Patents	665
International Patents	6,589
US Patent Applications	1,543
WIPO Patent Applications	864
Japanese Patent Applications	12
Clinical Trial Progress	Phase 2 (2013-11-01)
Vendors	75

US Patents for Ibudilast

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Ibudilast		Heterocyclic compound	Takeda Pharmaceutical Company Limited (Osaka, JP)
Ibudilast		Therapeutic approaches for treating Parkinson's disease	Pharnext (Issy les Moulineaux, FR)
Ibudilast		Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells	Selecta Biosciences, Inc. (Watertown, MA)
Ibudilast		Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag	The Catholic University of America (Washington, DC)
Ibudilast		Ultra-pure agonists of guanylate cyclase C, method of making and using same	SYNERGY PHARMACEUTICALS, INC. (New York, NY)
Ibudilast		Melanocortin-1 receptor-specific cyclic hexapeptides	Palatin Technologies, Inc. (Cranbury, NJ)
Ibudilast		Pyrazolopyridines and pyrazolopyrimidines	Pfizer Inc. (New York, NY)

International Patents for Ibudilast

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Ibudilast	Canada	2961033	2034-09-11
Ibudilast	European Patent Office	3192791	2034-09-11
Ibudilast	Japan	WO2016039408	2034-09-11
Ibudilast	World Intellectual Property Organization (WIPO)	2016039408	2034-09-11
Ibudilast	Australia	2012222348	2031-03-01
Ibudilast	Australia	2012222351	2031-03-01
Ibudilast	Australia	2013224959	2031-03-01